Related Experiment Video
Updated: Apr 6, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Fluticasone furoate for the treatment of childhood asthma
1Department of Pharmacy Practice and Science, University of Arizona Colleges of Pharmacy and Medicine, Tucson, AZ, USA.
Insights
Once-daily inhaled fluticasone furoate simplifies asthma management for children. This approach may improve adherence and outcomes, especially for adolescents transitioning to self-care.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Asthma Management
Background:
- Inhaled corticosteroids are beneficial for childhood asthma.
- Poor adherence is common, particularly in adolescents.
- Transition to self-management poses adherence challenges.
Purpose of the Study:
- To review the pharmacology, safety, and efficacy of fluticasone furoate for childhood asthma.
- To assess the potential of once-daily dosing to improve adherence.
- To identify areas for future research in younger children.
Main Methods:
- Review of existing literature on fluticasone furoate.
- Analysis of pharmacological properties.
- Evaluation of safety and efficacy data.
Main Results:
- Once-daily inhaled fluticasone furoate simplifies asthma therapy.
- Potential for improved adherence and outcomes in children and adolescents.
- Further study needed for safety and growth in younger populations.
Conclusions:
- Fluticasone furoate offers a simplified treatment option for childhood asthma.
- Adherence improvement is a key potential benefit.
- Ongoing research should focus on pediatric safety and efficacy.
Abstract:
Inhaled corticosteroids offer substantial benefit in controlling symptoms for the vast majority of children with asthma. However, poor adherence to therapy is very common, especially among older children and adolescents as they transition to self-management of their disease. The introduction of once-daily inhaled fluticasone furoate, either alone or in combination with the long-acting β-agonist, vilanterol, simplifies chronic asthma therapy and may improve adherence and as a result, outcomes in this vulnerable population. Opportunities exist for additional study of this agent in younger children, particularly with regard to safety and growth suppression. This review provides an overview of the pharmacology, safety and efficacy data regarding use of fluticasone furoate in the treatment of childhood asthma.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids

